Philippines Oncology Clinical Trials Market Analysis

Philippines Oncology Clinical Trials Market Analysis

$ 3999

The Philippines oncology clinical trials market is projected to grow from $27.8 Mn in 2022 to $44.4 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The market will be driven by the growing cancer burden, favorable regulatory environment, and cheaper costs. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & AstraZeneca plc.

ID: IN10PHCT006 CATEGORY: Clinical Trials GEOGRAPHY: Phillipines AUTHOR: Vidhi Upadhyay

Buy Now

Philippines Oncology Clinical Trials Market Executive Summary

The Philippines oncology clinical trials market is projected to grow from $27.8 Mn in 2022 to $44.4 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. Clinical trials are governed in the Philippines by the Department of Health (DOH) and the Food and Drug Administration (FDA) (FDA). The FDA is a DOH agency in charge of guaranteeing the safety, effectiveness, and quality of food, medicines, cosmetics, and medical devices. According to 2019 projections, the Philippine government supports slightly more than 40% of overall cancer costs, with out-of-pocket payments and private insurance covering the rest (Philippines Statistical Agency, 2020). Cancer is the Philippines' second biggest cause of mortality. Breast, lung, colorectal, liver, and prostate cancers are the most prevalent. Cancer is one of the main causes of mortality in the Philippines, of over 110 Mn people. Cancer was responsible for approximately 150,000 new diagnoses and over 90,000 fatalities in 2020 alone.

Because of its vast population and developing clinical research infrastructure, the Philippines is emerging as a destination for oncology clinical trials. Participation in oncology clinical trials in the nation has increased in recent years, with a focus on diseases such as breast cancer, lung cancer, and leukaemia. There has been a rise in the number of local and foreign pharmaceutical firms and research institutions conducting trials in the country, making it an important site for oncology clinical trials in Southeast Asia. The nation has the potential to become an even more prominent participant in the global cancer research landscape as it continues to invest in clinical research infrastructure and raise public awareness about clinical trials.

philippines oncology clinical trials market analysis

Market Dynamics

Market Growth Drivers

Recognizing the growing cancer burden, the government has recently increased its cancer-fighting efforts, as evidenced by the formation of the National Cancer Control Committee (NCCC), which is comprised of multi-stakeholder representatives from the government, patient organizations, and medical providers. The National Cancer Prevention and Control Action Plan (NCPCAP) 2015-2020 was designed and released by this group. The introduction of the Z-benefit package, as well as the recommendation that the DOH conduct cervical cancer screening and HPV vaccination programs, are key components of the strategy. The proposed National Integrated Cancer Control Strategy Plan for 2021-2030 is now being reviewed in order to properly overcome obstacles in transition and implementation. The growing cancer burden, a huge patient pool, competent healthcare workers, and government support are all key factors for oncology clinical trials in the Philippines. The favorable regulatory environment and cheaper costs also attract multinational corporations. The pandemic's trend toward virtual and decentralized testing might fuel additional expansion.

Market Restraints

In a 2020 WPRO assessment, the Philippines placed last in policy, planning, and care delivery, and ninth out of ten nations in health system governance. There are also several other barriers to the expansion of oncology clinical trials in the Philippines. One of the most significant barriers is the general public's lack of knowledge and comprehension of clinical trials. Many Filipinos are unfamiliar with clinical trials, and there is a need to raise awareness and educate people about the advantages of clinical research. Another barrier is the regulatory framework in the Philippines for clinical studies. Although the government has made steps to shorten the regulatory procedure for clinical trials, acquiring the requisite clearances and licenses for clinical research still involves considerable complexity. This might increase the time and expense of performing clinical studies in the nation.

Competitive Landscape

Key Players

  • Pfizer Inc.
  • Novartis International AG
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Roche Holding AG
  • Eli Lilly and Company
  • Sanofi S.A.
  • Bristol Myers Squibb Company
  • Specialized Therapeutics

Notable Insights

  1. July 2022, Nerlynx (neratinib), an oral medication developed by specialized Therapeutics, has been approved by the Philippines Food and Drug Administration to reduce the risk of recurrence or death in patients with early-stage HER2-positive (HER2+) breast cancer.
  2. In July 2022, The Philippine Food and Drug Administration (FDA) approved alpelisib in combination with fulvestrant for the treatment of postmenopausal women and men with hormone receptor-positive, human epidermal growth factor receptor-2 negative (HR+/HER2-), PIK3CA-mutated, in advanced or metastatic breast cancer after disease progression following an endocrine-based regimen.
  3. In May 2022, Novartis Philippines has launched a PIK3CA Breast Cancer Testing Program.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company Overview Product Applications and Services Recent Developments Partnerships Ecosystem Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Philippines Oncology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook  (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.


Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:



Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.



Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 20 March 2023
Updated by: Bhanu Pratap Singh

Related reports (by category)

Related reports (by geography)

subscribe to our newsletter